Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
Breast Cancer Research 2008, 10:102doi:10.1186/bcr1854
See related research article by Crabb et al., http://breast-cancer-research.com/content/10/1/R6 AbstractAn urgent requirement exists for new prognostic and predictive assays in breast cancer. Despite the development of high-throughput technologies such as DNA microarrays, it would now appear that immunohistochemistry (IHC) may play an increasingly important role in the clinical management of breast cancer. In this editorial, the authors discuss the potential prognostic ability of a panel of IHC markers, and question whether this well-established assay technology may in fact allow for improved prognostic and predictive tests in breast cancer. |



on Google Scholar






author email
corresponding author email